These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26377840)

  • 1. Early Changes of Mannose-Binding Lectin, H-Ficolin, and Procalcitonin in Patients with Febrile Neutropenia: A Prospective Observational Study.
    Işlak Mutcalı S; Saltoğlu N; Balkan İİ; Özaras R; Yemişen M; Tabak F; Mert A; Öztürk R; Öngören Ş; Başlar Z; Aydın Y; Ferhanoğlu B; Soysal T
    Turk J Haematol; 2016 Dec; 33(4):304-310. PubMed ID: 26377840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections.
    Kilpatrick DC; McLintock LA; Allan EK; Copland M; Fujita T; Jordanides NE; Koch C; Matsushita M; Shiraki H; Stewart K; Tsujimura M; Turner ML; Franklin IM; Holyoake TL
    Clin Exp Immunol; 2003 Nov; 134(2):279-84. PubMed ID: 14616788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
    Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
    PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
    Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
    Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
    von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
    Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India.
    Halder R; Seth T; Chaturvedi PK; Mishra P; Mahapatra M; Pati HP; Tyagi S; Saxena R
    Blood Cells Mol Dis; 2020 Sep; 84():102445. PubMed ID: 32480243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
    Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy.
    Vekemans M; Robinson J; Georgala A; Heymans C; Muanza F; Paesmans M; Klastersky J; Barette M; Meuleman N; Huet F; Calandra T; Costantini S; Ferrant A; Mathissen F; Axelsen M; Marchetti O; Aoun M
    Clin Infect Dis; 2007 Jun; 44(12):1593-601. PubMed ID: 17516403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
    Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia.
    Jimeno A; García-Velasco A; del Val O; González-Billalabeitia E; Hernando S; Hernández R; Sánchez-Muñoz A; López-Martín A; Durán I; Robles L; Cortés-Funes H; Paz-Ares L
    Cancer; 2004 Jun; 100(11):2462-9. PubMed ID: 15160353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two factors of the lectin pathway of complement, l-ficolin and mannan-binding lectin, and their associations with prematurity, low birthweight and infections in a large cohort of Polish neonates.
    Swierzko AS; Atkinson AP; Cedzynski M; Macdonald SL; Szala A; Domzalska-Popadiuk I; Borkowska-Klos M; Jopek A; Szczapa J; Matsushita M; Szemraj J; Turner ML; Kilpatrick DC
    Mol Immunol; 2009 Feb; 46(4):551-8. PubMed ID: 18950864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Luethy AR; Leibundgut K; Hirt A; Ammann RA
    Pediatr Blood Cancer; 2007 Jul; 49(1):11-6. PubMed ID: 17143875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies.
    Baraka A; Zakaria M
    Int J Hematol; 2018 Aug; 108(2):184-191. PubMed ID: 29616457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentration of complement components of the lectin pathway in maintenance hemodialysis patients, and relatively higher levels of L-Ficolin and MASP-2 in Mannose-binding lectin deficiency.
    Ishii M; Ohsawa I; Inoshita H; Kusaba G; Onda K; Wakabayashi M; Ohi H; Horikoshi S; Matsushita M; Tomino Y
    Ther Apher Dial; 2011 Oct; 15(5):441-7. PubMed ID: 21974696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia.
    Aimoto M; Koh H; Katayama T; Okamura H; Yoshimura T; Koh S; Nanno S; Nishimoto M; Hirose A; Nakamae M; Nakane T; Nakamae H; Kakeya H; Hino M
    Infection; 2014 Dec; 42(6):971-9. PubMed ID: 25038889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M-ficolin levels are associated with the occurrence of severe infections in patients with haematological cancer undergoing chemotherapy.
    Ameye L; Paesmans M; Thiel S; Jensenius JC; Aoun M
    Clin Exp Immunol; 2012 Feb; 167(2):303-8. PubMed ID: 22236007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic and prognostic value of angiopoietins compared with C-reactive protein and procalcitonin in children with febrile neutropenia.
    Mimaroğlu E; Çıtak EÇ; Kuyucu N; Eskendari G
    Turk J Pediatr; 2017; 59(4):418-425. PubMed ID: 29624222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.
    Koivula I; Hämäläinen S; Jantunen E; Pulkki K; Kuittinen T; Nousiainen T; Juutilainen A
    Scand J Infect Dis; 2011 Jul; 43(6-7):471-8. PubMed ID: 21299364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia.
    Özdemir ZC; Düzenli-Kar Y; Canik A; Küskü-Kiraz Z; Özen H; Bör Ö
    Turk J Pediatr; 2019; 61(3):359-367. PubMed ID: 31916713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.
    Prat C; Sancho JM; Dominguez J; Xicoy B; Gimenez M; Ferra C; Blanco S; Lacoma A; Ribera JM; Ausina V
    Leuk Lymphoma; 2008 Sep; 49(9):1752-61. PubMed ID: 18661397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.